| |
Active Ingredients / Generics:
benperidol
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.8 - Undesirable Effects
|
Active Ingredients / Generics:
dutasteride
- Change of manufacturer
- Change to drug interactions
|
Active Ingredients / Generics:
nicotine
- Correction of spelling/typing errors
|
Active Ingredients / Generics:
triptorelin acetate
- Change/addition of instructions for reconstitution and/ or administration
- Change to date of revision
|
Active Ingredients / Generics:
salbutamol sulphate
- Correction of spelling/typing errors
|
Active Ingredients / Generics:
sodium valproate
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and Lactation
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
sodium valproate
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and Lactation
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
sodium valproate
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and Lactation
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
erdosteine
- Removal/change of distributor
|
Active Ingredients / Generics:
crotamiton
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
heparin calcium
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for Use
|
Active Ingredients / Generics:
heparin sodium
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for Use
|
Active Ingredients / Generics:
heparin sodium
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for Use
|
Active Ingredients / Generics:
heparin sodium
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for Use
|
Active Ingredients / Generics:
heparin sodium
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for Use
|
Active Ingredients / Generics:
heparin sodium
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for Use
|
Active Ingredients / Generics:
aluminium hydroxide gel, magnesium hydroxide
- Change due to user-testing of patient information
|
Active Ingredients / Generics:
carbocisteine
- Change to manufacturer contact details
|
Active Ingredients / Generics:
octreotide
- Change to name of manufacturer
- Change to MA holder contact details
|
Active Ingredients / Generics:
ketoprofen
- Change to manufacturer contact details
|
Active Ingredients / Generics:
xylometazoline hydrochloride, antazoline sulphate
- Change to section 7 - Marketing Authorisation Holder
- Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
|
Active Ingredients / Generics:
promethazine hydrochloride
- Change to name of manufacturer
|
Active Ingredients / Generics:
promethazine hydrochloride
- Change to manufacturer contact details
- Change to name of manufacturer
|
Active Ingredients / Generics:
promethazine hydrochloride
- Change due to user-testing of patient information
|
Active Ingredients / Generics:
tretinoin
- Change to date of revision, PIL Retired combination of strengths
|
Active Ingredients / Generics:
chlorhexidine gluconate
- Change to section 6. 3 - Shelf Life
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
amisulpride
- Change to manufacturer contact details
|
Active Ingredients / Generics:
prochlorperazine mesilate
|
Active Ingredients / Generics:
diazepam
- Change due to user-testing of patient information
|
Active Ingredients / Generics:
trimipramine maleate
- Change due to user-testing of patient information
|
Active Ingredients / Generics:
diltiazem hydrochloride
- Change to warnings or special precautions for use
- Change to side-effects
- Change to drug interactions
|
Active Ingredients / Generics:
distigmine bromide
- Change to manufacturer contact details
|
Active Ingredients / Generics:
salbutamol sulphate
- Change to Further Information section
|
Active Ingredients / Generics:
diclofenac sodium
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and Lactation
|
| |
Active Ingredients / Generics:
loratadine
- New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
Active Ingredients / Generics:
hydrochlorothiazide, captopril
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 6. 5 - Nature and Contents of Container
|
Active Ingredients / Generics:
podophyllotoxin
- New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
|
Active Ingredients / Generics:
ketoconazole
|
Active Ingredients / Generics:
liquid paraffin, wool alcohols, acetylated
- New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
|
Active Ingredients / Generics:
eptifibatide
- Change/addition of instructions for reconstitution and/ or administration
- Change to Further Information section
- Change to date of revision
- Change to warnings or special precautions for use
- Change to information about pregnancy or lactation
|
Active Ingredients / Generics:
eptifibatide
- Change/addition of instructions for reconstitution and/ or administration
- Change to Further Information section
- Change to date of revision
- Change to warnings or special precautions for use
- Change to information about pregnancy or lactation
|
Active Ingredients / Generics:
light liquid paraffin
|
Active Ingredients / Generics:
acipimox
- Change to side-effects
- Change to information about driving or using machinery
|
Active Ingredients / Generics:
phenytoin sodium
- Improved Electronic Presentation
|
Active Ingredients / Generics:
parathyroid hormone
- Change to date of revision
|
Active Ingredients / Generics:
artemether, lumefantrine
- Change to section 4.8 - Undesirable Effects
|
Active Ingredients / Generics:
dopamine hydrochloride
- New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
|
Active Ingredients / Generics:
potassium chloride
- Improved Electronic Presentation
|
Active Ingredients / Generics:
typhoid vaccine
- Change to section 6.1 - List of Excipients
- Change to section 6. 3 - Shelf Life
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 7 - Marketing Authorisation Holder
- Change to section 9 - Date of first Authorisation/renewal of the Authorisation
- Change to section 10 date of revision of the text
|
| |
Active Ingredients / Generics:
risedronate sodium
- Change to section 6. 3 - Shelf Life
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
calcium carbonate, vitamin d3 (colecalciferol)
- Improved Electronic Presentation
|
Active Ingredients / Generics:
diphenhydramine hydrochloride, levomenthol
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
guaifenesin
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
diphenhydramine hydrochloride, levomenthol
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
dextromethorphan hydrobromide
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
diphenhydramine hydrochloride, dextromethorphan hydrobromide, levomenthol
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
demeclocycline hydrochloride
- Change to date of revision
|
Active Ingredients / Generics:
triamterene
- New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
|
Active Ingredients / Generics:
folic acid
- Improved Electronic Presentation
|
Active Ingredients / Generics:
nitrofurantoin
- Improved Electronic Presentation
|
Active Ingredients / Generics:
nitrofurantoin
- Improved Electronic Presentation
|
Active Ingredients / Generics:
nitrofurantoin
- Improved Electronic Presentation
|
Active Ingredients / Generics:
guaifenesin, pseudoephedrine hydrochloride, triprolidine hydrochloride
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
dextromethorphan hydrobromide, pseudoephedrine hydrochloride, triprolidine hydrochloride
- Change to section 6. 5 - Nature and Contents of Container
|
Active Ingredients / Generics:
dextromethorphan hydrobromide, pseudoephedrine hydrochloride
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
guaifenesin, pseudoephedrine hydrochloride
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
follitropin beta
- Change due to user-testing of patient information
|
Active Ingredients / Generics:
follitropin beta
- Change due to user-testing of patient information
|
Active Ingredients / Generics:
follitropin beta
- Change due to user-testing of patient information
|
Active Ingredients / Generics:
dexrazoxane hydrochloride
- New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
Active Ingredients / Generics:
diclofenac sodium
- Change to storage instructions
- Change to Marketing Authorisation Holder
|
Active Ingredients / Generics:
ustekinumab
- Change to date of revision, Correction of spelling/typing errors
|
Active Ingredients / Generics:
efavirenz
- Introduction of new pack/pack size
|
Active Ingredients / Generics:
topiramate
- Change of trade or generic name
- Change to Further Information section
- Change to date of revision
- Change to, or new, use for medicine
- Change to warnings or special precautions for use
- Change of contra-indications
- Change to instructions about missed dose
- Change to instructions about overdose
- Change to side-effects
- Change to drug interactions
- Change to information about drinking alcohol
- Change to information about pregnancy or lactation
- Change to information about driving or using machinery
|
Active Ingredients / Generics:
topiramate
- Change of trade or generic name
- Change to Further Information section
- Change to date of revision
- Change to, or new, use for medicine
- Change to warnings or special precautions for use
- Change of contra-indications
- Change to instructions about missed dose
- Change to instructions about overdose
- Change to side-effects
- Change to drug interactions
- Change to information about drinking alcohol
- Change to information about pregnancy or lactation
- Change to information about driving or using machinery
|